Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)

Mueez Waqar, Federico Roncaroli, Eric J. Lehrer, Joshua D. Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C. De Witt Hamer, Pietro I. D'Urso, Daniel Trifiletti, Alfredo Quiñones-Hinojosa, Pieter Wesseling, Gerben R. Borst

Research output: Contribution to journalComment/debatepeer-review

Abstract

This is an erratum to: Mueez Waqar, Federico Roncaroli, Eric J Lehrer, Joshua D Palmer, Javier Villanueva-Meyer, Steve Braunstein, Emma Hall, Marianne Aznar, Philip C De Witt Hamer, Pietro I D'Urso, Daniel Trifiletti, Alfredo Quiñones- Hinojosa, Pieter Wesseling, Gerben R Borst, Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac075, https://doi.org/10.1093/ noajnl/vdac075 In the originally published version of this manuscript, the surname of author Gerben R Borst was inadvertently misspelled as Gerben R Bors. This error has been corrected.

Original languageEnglish (US)
Article numbervdac125
JournalNeuro-Oncology Advances
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2022

ASJC Scopus subject areas

  • Clinical Neurology
  • Oncology
  • Surgery

Fingerprint

Dive into the research topics of 'Erratum: Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis (Neuro-Oncology Advances (2022) 4:1 (vdac075) DOI: 10.1093/noajnl/vdac075)'. Together they form a unique fingerprint.

Cite this